Abstract:OBJECTIVE: We report a Chinese family with CCM and want to investigate clinical, pathological, magnetic resonance imaging features and pathogenic gene mutation of this family. BACKGROUND: Familial cerebral cavernous malformation(CCM), characterized by hemorrhagic stroke, recurrent headaches and epilepsy, is caused by abnormal capillary telangiectasis of central nervous system. Family CCM is an autosomal dominant inherited disorder and three CCM genes have been identified. DESIGN/METHODS: In the Chinese family, all individuals underwent brain magnetic resonance imaging (MRI) examination and clinical check. The special patients with surgical indications had surgical treatment and the specimens were performed histopathological examination. In addition, polymerase chain reaction (PCR) and direct sequence analysis were performed with genomic DNA extracted from 25 family members9 blood samples for mutation detection. RESULTS: Among the 25 individuals participating in our investigation, 7 patients with CCM, including 5 male, 2 female. The clinical manifestations are variable as well as the age of onset and number of lesions within the family.MRI and Gradient-echo(GRE) sequence are more sensitive to find microcavernous hemangiomas .Histopathologic examination results show CCM lesions are typically discrete multisublobes berrylike lesions. They consist of endothelial-linked sinusoidal spaces not separated by significant amounts of neural tissue. Mutation detection in all the affected patients shows a novel mutation, deletion of a T (c.1396delT) in exon 14 of CCM1 gene. CONCLUSIONS: The diversity clinical manifestations have varied to a large extent on the age of onset and severity, there is a strong correlation between number of lesions and age: the younger, the less. The skin and brain CCM coincidence rate is 100%. MRI is the most sensitive modality for the diagnosis of CCM. Pathological examination can only used for patients with serious hemiplegia and surgical indications. A novel mutation (c.1396delT) is co-segregated with the phenotype of patients and the disease-causing mutation for this family. Supported by: National Natural Science Foundation of China (No. H0905) and the National Natural Science Foundation of Shandong province (No. ZR2010HM052). Disclosure: Dr. Liu has nothing to disclose. Dr. Wang has nothing to disclose. Dr. Lee has nothing to disclose. Dr. Liu has nothing to disclose.

Single-nucleus DNA sequencing reveals hidden somatic loss-of-heterozygosity in Cerebral Cavernous Malformations

Loss of heterozygosity in CCM2 cDNA revealing a structural variant causing multiple cerebral cavernous malformations

Somatic Mutations in Cerebral Cortical Malformations.

A personalized multi-platform assessment of somatic mosaicism in the human frontal cortex

Somatic variants of MAP3K3 are sufficient to cause cerebral and spinal cord cavernous malformations

Somatic MAP3K3 and PIK3CA mutations in sporadic cerebral and spinal cord cavernous malformations

Transcriptomic signatures of individual cell types in cerebral cavernous malformation

Cerebral cavernous malformations do not fall in the spectrum of PIK3CA-related overgrowth

Mapping endothelial-cell diversity in cerebral cavernous malformations at single-cell resolution

A novel CCM3 mutation associated with cerebral cavernous malformation in a Chinese family

Comprehensive identification of somatic nucleotide variants in human brain tissue

Identification of a Novel CCM1 Frameshift Mutation in a Chinese Han Family With Multiple Cerebral Cavernous Malformations

Novel KRIT1/CCM1 and MGC4607/CCM2 Gene Variants in Chinese Families with Cerebral Cavernous Malformations

A Novel CCM2 Gene Mutation Associated With Cerebral Cavernous Malformation

A Novel CCM1 Gene Mutation Causes Cerebral Cavernous Malformation in a Chinese Family

Cerebral cavernous malformations associated to meningioma: High penetrance in a novel family mutated in the PDCD10 gene

Features of a Chinese Family with Cerebral Cavernous Malformation Induced by a Novel CCM1 Gene Mutation

Comprehensive analysis of Novel mutations in CCM1/KRIT1 and CCM2/MGC4607 and their clinical implications in Cerebral Cavernous malformations

Somatic Point Mutation Calling in Low Cellularity Tumors

Clinical, Pathological, Magnetic Resonance Imaging Features of a Chinese Family with Cerebral Cavernous Malformation Induced by a Novel CCM1 Gene Mutation (P07.232)

Molecular Genetic Features of Cerebral Cavernous Malformations (CCM) Patients: An Overall View from Genes to Endothelial Cells